☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
4D pharma
4D Pharma Presents Results of MRx-4DP0004 in P-I/II Trial for the Treatment of Asthma at ATS 2022
May 18, 2022
4D pharma Reports Results of MRx-4DP0004 in Part A of the P-I/II Trial for the Treatment of Asthma
January 28, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.